"Our ability to control our thoughts is fundamental to our wellbeing," said Michael Anderson from the University of Cambridge in the UK.
"When this capacity breaks down, it causes some of the most debilitating symptoms of psychiatric diseases: intrusive memories, images, hallucinations, ruminations, and pathological and persistent worries," said Anderson.
"These are all key symptoms of mental illnesses such as PTSD, schizophrenia, depression, and anxiety," he said.
A region at the front of the brain known as the prefrontal cortex is known to play a key role in controlling our actions and has more recently been shown to play a similarly important role in stopping our thoughts.
The prefrontal cortex acts as a master regulator, controlling other brain regions - the motor cortex for actions and the hippocampus for memories.
In the study published in the journal Nature Communications, scientists used a task known as the 'Think/No-Think' procedure to identify a significant new brain process that enables the prefrontal cortex to successfully inhibit our thoughts.
In the next stage, they were asked to recall the associated word if the cue is green or to suppress it if the cue is red; in other words, when shown 'ordeal' in red, they were asked to stare at the word but to stop themselves thinking about the associated thought 'roach'.
Using a combination of functional magnetic resonance imaging (fMRI) and magnetic resonance spectroscopy, the researchers were able to observe what was happening within key regions of the brain as the participants tried to inhibit their thoughts.
GABA is the main 'inhibitory' neurotransmitter in the brain, and its release by one nerve cell can suppress activity in other cells to which it is connected.
Researchers discovered that GABA concentrations within the hippocampus - a key area of the brain involved in memory - predict people's ability to block the retrieval process and prevent thoughts and memories from returning.
Anderson believes the finding could offer a new approach to tackling intrusive thoughts in these disorders.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
